Advanced Biomed Inc.
ADVB· Nasdaq
ADVBAdvanced Biomed Inc.
Filed May 15, 2026 · 10-Q · 45 days after period end · 0001213900-26-057226
| Metric | Q3 2026 | Q3 2025 | Q3 2024 |
|---|---|---|---|
| Net Income | -$488.94K | -$1.38M | -$1.06M |
| EPS Diluted | -$0.38 | -$1.35 | -$0.05 |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Advanced Biomed Inc. · CIK 1941029 · Engraved from SEC EDGAR
ended Mar 31, 2026 · filed May 15, 2026 · 45 d after period end
